Related Experiment Video
Updated: Aug 11, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Spindle function and Wnt pathway inhibition by PBX1 to suppress tumor progression via downregulating DCDC2 in
Weigang Dai1,2, Yinan Liu1,2,3, Tianhao Zhang1,2
1Division of Gastrointestinal Surgery Center, the First Affiliated Hospital of Sun Yat-sen University, 510080, Guangzhou, Guangdong, P. R. China.
Abstract:
PBX1 is a transcription factor that regulates a variety of genes, involved in intracellular lipid metabolism, cell proliferation, and other pathways. The promoting and inhibiting function of PBX1 in various cancer types was extensively discussed, however, there have been no studies on PBX1 proteins in colorectal cancer (CRC). This study aimed to reveal the anti-tumor function of PBX1 in CRC and the underlying molecular mechanism. Bioinformatics analysis revealed that PBX1 is downregulated in CRC, indicating that is a potential antioncogene in CRC. Overexpression of PBX1 suppresses tumor growth and metastasis in vitro and in vivo. Mechanistically, we found that PBX1 acted as a transcription factor that suppressed DCDC2 expression and inhibited spindle function. Moreover, the PBX1-DCDC2 axis controlled the Wnt pathway in CRC cells. Overexpression of DCDC2 restored CRC proliferation, metastasis abilities and Wnt pathway. In conclusion, this study suggests that PBX1 acts as a transcription factor to suppress DCDC2 expression and inhibit cell proliferation and metastasis by disrupting spindle function and the Wnt pathway in CRC.
Insights
PBX1 acts as an antioncogene in colorectal cancer (CRC). Overexpressing PBX1 suppresses tumor growth and metastasis by inhibiting DCDC2 expression, disrupting spindle function, and modulating the Wnt pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PBX1 is a transcription factor regulating lipid metabolism and cell proliferation.
- Its role in various cancers is known, but its function in colorectal cancer (CRC) remains unstudied.
- PBX1's dual role necessitates investigation in specific cancer contexts.
Purpose of the Study:
- To elucidate the anti-tumor function of PBX1 in colorectal cancer (CRC).
- To identify the molecular mechanisms underlying PBX1's action in CRC.
- To determine PBX1's potential as a therapeutic target in CRC.
Main Methods:
- Bioinformatics analysis to assess PBX1 expression in CRC.
- In vitro and in vivo experiments to evaluate the effects of PBX1 overexpression.
- Mechanistic studies involving gene expression analysis (DCDC2) and pathway investigation (Wnt).
Main Results:
- PBX1 is significantly downregulated in CRC, suggesting antioncogenic activity.
- PBX1 overexpression suppressed tumor growth and metastasis in CRC models.
- PBX1 functions by suppressing DCDC2 expression, inhibiting spindle function, and impacting the Wnt pathway.
Conclusions:
- PBX1 acts as a tumor suppressor in colorectal cancer.
- The PBX1-DCDC2 axis is a critical regulator of CRC progression via spindle and Wnt pathway modulation.
- Targeting PBX1 may offer a novel therapeutic strategy for colorectal cancer.
Related Concept Videos
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Pleiotropy
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
The Intrinsic Apoptotic Pathway

